Keyphrases
NF-B
66%
Tumor
34%
Common Lymphoid Progenitor
33%
Immature Myeloid Cells
33%
Macrophages
28%
CEBPA
26%
T Cells
26%
B Lymphopoiesis
25%
Myeloid Cells
23%
ProB
22%
Tumor Growth
22%
Glioblastoma multiforme
20%
Gene Expression
20%
Adoptive Transfer
18%
Nuclear Translocation
16%
Phosphorylation
16%
Anti-LAG-3
16%
High-risk Neuroblastoma
16%
Glioblastoma
16%
Tumor Regression
16%
Bortezomib
16%
Myeloid Infiltration
16%
Prostate Cancer Cells
16%
Anti-PD-1 Monoclonal Antibody
16%
EBF1
16%
Tumor-associated Macrophages
16%
REDD+
16%
Combination Treatment
16%
Proteins Control
16%
Autophagosome-lysosome Fusion
16%
M2 Macrophage Polarization
16%
Humanized
16%
Prostate Cancer Localization
16%
Phagocytosis
16%
Cetuximab
16%
CD8+ T Cells
14%
Autophagy
13%
Knockdown
13%
Immune Checkpoint Inhibitors
12%
B Cells
11%
Cre Mice
11%
PC-3 Cells
10%
M2 Polarization
10%
Syngeneic
10%
FMS-like Tyrosine Kinase 3 (FLT3)
9%
Tumor Immunity
9%
P65 Phosphorylation
8%
Anti-PD-1
8%
Blocking Antibodies
8%
Tumor-associated Myeloid Cells
6%
Immunology and Microbiology
Myeloid
100%
T Cell
48%
Mouse
44%
Macrophage
32%
Cytotoxic T-Cell
32%
Enhancer Region
30%
Tumor-Associated Macrophage
30%
Wild Type
28%
Lymphopoiesis
27%
M2 Macrophages
23%
Cancer Cell
19%
Gene Expression
19%
Dendritic Cell
19%
Genetic Transfection
16%
Lysosome
16%
Normal Human
16%
Autophagy
16%
Interleukin 8
16%
Protein Degradation
16%
Genetic Transcription
16%
B Cell
16%
Precursor
16%
Autophagosome
16%
Humanized Antibody
16%
Cetuximab
16%
Phagocytosis
16%
CD8
14%
Syngenic
13%
Prostate
13%
Monocyte
12%
Transcription Factors
11%
Knockout Mouse
10%
Granulocyte
8%
Proteasome
8%
T-Helper Cell
7%
Macrophage Colony-Stimulating Factor
6%
Adaptive Immune System
6%
Cytokine
6%
Gene Expression Profiling
6%
T Cell Depletion
5%
Signal Transduction
5%
Transgene
5%
Xenograft
5%
Medicine and Dentistry
Myeloid Cell
45%
Neoplasm
43%
Epileptic Absence
33%
Prostate Cancer
33%
Macrophage
25%
Cytotoxic T-Cell
21%
M2 Macrophages
21%
Enhancer Region
20%
Tumor Regression
16%
Gene Expression
16%
Serine
16%
Tumor Necrosis Factor
16%
Nuclear Factor
16%
Alternative Complement Pathway C3 C5 Convertase
16%
Cancer Growth
16%
T Cell
16%
Glioblastoma
16%
Cancer Localization
16%
Phagocytosis
16%
Cetuximab
16%
Epidermal Growth Factor Receptor
11%
Lymphopoiesis
11%
Monocyte
10%
Granulocyte
8%
RNA Polymerase II
6%
Fibroblast
6%
Ganglioglioma
6%
Transcription Factors
6%
Nucleofection
5%
